Skip to main content
Kelly Bree, MD, Urology, Houston, TX, University of Texas M.D. Anderson Cancer Center

KellyKatherineBreeMD(She/Her)

Urology Houston, TX

Surgical Oncology

Assistant Professor and Urologic Oncology Surgeon at the University of Texas MD Anderson Cancer Center

Dr. Bree is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bree's full profile

Already have an account?

Summary

  • Dr. Kelly Bree is an urologic oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her medical degree from George Washington University School of Medicine and has been in practice 2 years. She specializes in surgical management of kidney, bladder and prsotate cancers. She has more than 20 peer-reviewed articles and book chapters.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2020 - 2022
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Surgery, 2014 - 2019
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 2014

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2025
  • CA State Medical License
    CA State Medical License 2016 - 2023

Publications & Presentations

PubMed

Press Mentions

  • Study Charts Uptick in Unnecessary CT, MR Imaging Surveillance of Noninvasive Bladder Cancer
    Study Charts Uptick in Unnecessary CT, MR Imaging Surveillance of Noninvasive Bladder CancerMarch 21st, 2022
  • Overuse of Surveillance in Bladder Cancer, Despite Guidelines
    Overuse of Surveillance in Bladder Cancer, Despite GuidelinesSeptember 6th, 2022
  • Risk Stratification Examined for High-Grade Ta Bladder Tumors
    Risk Stratification Examined for High-Grade Ta Bladder TumorsSeptember 6th, 2022

Hospital Affiliations